Niox Group PLC Announces Change in Voting Rights

Circassia Pharmaceuticals ( (GB:NIOX) ) has shared an update.

Niox Group PLC, a UK-based company, has undergone a change in its voting rights structure due to an acquisition or disposal by Danske Bank A/S, a financial institution based in Copenhagen, Denmark. The notification indicates that Danske Bank’s voting rights in Niox Group have decreased from 3.43072% to 2.99176%, as of May 23, 2025. This change reflects a shift in the company’s shareholder dynamics, potentially impacting its governance and decision-making processes.

The most recent analyst rating on (GB:NIOX) stock is a Buy with a £77.00 price target. To see the full list of analyst forecasts on Circassia Pharmaceuticals stock, see the GB:NIOX Stock Forecast page.

Spark’s Take on GB:NIOX Stock

According to Spark, TipRanks’ AI Analyst, GB:NIOX is a Neutral.

Circassia Pharmaceuticals’ strong financial performance and strategic growth initiatives are key strengths. However, high valuation and potential downtrend in stock price temper the overall outlook. Despite positive corporate developments, some uncertainties remain.

To see Spark’s full report on GB:NIOX stock, click here.

More about Circassia Pharmaceuticals

Average Trading Volume: 1,839,409

Technical Sentiment Signal: Strong Buy

Current Market Cap: £265.8M

For a thorough assessment of NIOX stock, go to TipRanks’ Stock Analysis page.